The Role of Ustekinumab in UC

Millie Long, David Hudesman, MD, Maia Kayal, MD, and Miguel Regueiro, MD, discuss treatment strategies for ulcerative colitis (UC) utilizing ustekinumab.

Related Content:

Examining the Long-term Clinical Evidence of Therapies for Inflammatory Bowel Disease in Bio-naïve PatientsGastroenterology

Insulin Resistance Amplifies Risk of Colorectal Cancer Development

Study Discovers Constipation Has a Causal Relationship with Schizophrenia, MDD

Lower Diet Diversity, Quality Linked to More Severe IBS Symptoms